{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:19:18Z","timestamp":1787764758369,"version":"build-2784847793"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["CSDG-22-125-01-HOPS"],"award-info":[{"award-number":["CSDG-22-125-01-HOPS"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.surg.2026.110344","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:22:43Z","timestamp":1780118563000},"page":"110344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Validation of previously proposed criteria for selecting nonulcerated T1b melanoma patients for sentinel lymph node biopsy"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1229-7844","authenticated-orcid":false,"given":"Piamonte","family":"Quinn L","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donica","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephens","family":"Kyle R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philips","family":"Prejesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McMasters","family":"Kelly M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8263-751X","authenticated-orcid":false,"given":"Egger","family":"Michael E","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2026.110344_bib1","series-title":"Cutaneous Melanoma (Version 2.2025)","year":"2025"},{"key":"10.1016\/j.surg.2026.110344_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1245\/ASO.2005.04.027","article-title":"Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas","volume":"12","author":"Kesmodel","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2026.110344_bib3","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","article-title":"Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma","volume":"31","author":"Han","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110344_bib4","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/jso.24765","article-title":"The natural history of thin melanoma and the utility of sentinel lymph node biopsy","volume":"116","author":"Durham","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.surg.2026.110344_bib5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.6004\/jnccn.2009.0023","article-title":"Role of sentinel lymph node biopsy in patients with thin melanoma","volume":"7","author":"Andtbacka","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.surg.2026.110344_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jso.27976","article-title":"Are nomograms useful for predicting sentinel lymph node status in Melanoma patients?","volume":"131","author":"Lourdault","year":"2025","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.surg.2026.110344_bib7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jamcollsurg.2018.12.030","article-title":"Should sentinel lymph node Biopsy be performed for all T1b Melanomas in the new 8(th) Edition American Joint Committee on cancer staging system?","volume":"228","author":"Egger","year":"2019","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2026.110344_bib8","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1200\/JCO.19.02362","article-title":"Improved risk prediction calculator for Sentinel node positivity in patients with melanoma: the melanoma Institute Australia nomogram","volume":"38","author":"Lo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110344_bib9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0300891620969827","article-title":"Development and validation of a Brazilian nomogram to assess sentinel node biopsy positivity in melanoma","volume":"107","author":"Bertolli","year":"2021","journal-title":"Tumori"},{"key":"10.1016\/j.surg.2026.110344_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamasurg.2023.6904","article-title":"Population-based validation of the MIA and MSKCC tools for predicting sentinel lymph node status","volume":"159","author":"Olofsson Bagge","year":"2024","journal-title":"JAMA Surg"},{"key":"10.1016\/j.surg.2026.110344_bib11","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.surg.2026.110344_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1245\/ASO.2006.03.092","article-title":"American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma","volume":"13","author":"Vaquerano","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2026.110344_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jso.26723","article-title":"More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: a Danish population-based study of 7148 patients","volume":"125","author":"Weitemeyer","year":"2022","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.surg.2026.110344_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/XCS.0000000000001296","article-title":"Predictors of SLNB in thin melanoma: understanding the impact of the American Joint Committee on cancer 8th edition staging system","volume":"240","author":"Donica","year":"2025","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2026.110344_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245878","article-title":"Sentinel lymph node Biopsy vs. observation in thin melanoma: a multicenter propensity score matching study","volume":"10","author":"Tejera-Vaquerizo","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.surg.2026.110344_bib16","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jamadermatol.2017.2497","article-title":"Association between patient age and lymph node positivity in thin melanoma","volume":"153","author":"Sinnamon","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.surg.2026.110344_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaad.2018.08.051","article-title":"Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database","volume":"80","author":"Conic","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.surg.2026.110344_bib18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2016.10.018","article-title":"Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013","volume":"76","author":"Landow","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.surg.2026.110344_bib20","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/cncr.33612","article-title":"Histopathologic synoptic reporting of invasive melanoma: how reliable are the data?","volume":"127","author":"Taylor","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2026.110344_bib21","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s12094-019-02064-4","article-title":"Mitotic rate as an important prognostic factor in cutaneous malignant melanoma","volume":"21","author":"Pinero-Madrona","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.surg.2026.110344_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejso.2016.06.407","article-title":"Complications of sentinel lymph node biopsy for melanoma - a systematic review of the literature","volume":"43","author":"Moody","year":"2017","journal-title":"Eur J Surg Oncol"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026002692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026002692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:33:28Z","timestamp":1787762008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606026002692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"alternative-id":["S0039606026002692"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2026.110344","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of previously proposed criteria for selecting nonulcerated T1b melanoma patients for sentinel lymph node biopsy","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2026.110344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110344"}}